News
Should tariffs on pharmaceutical imports go into effect as President Trump is intimating, it would cause U.S. drug prices to ...
The transaction, which sources say could be agreed upon as soon as Monday, would price SpringWorks at $47 per share, totaling ...
AbbVie is now pushing Skyrizi and Rinvoq to counter the drop in Humira sales and has forecast the two newer drugs to generate ...
Shares of SpringWorks Therapeutics (NASDAQ:SWTX) reached a session high on Thursday after The Wall Street Journal reported ...
Air India is in talks with U.S. planemaker Boeing to acquire around 10 737 MAX jets after Chinese customers started rejecting ...
SHANGHAI (Reuters) -The Beijing-based American Chamber of Commerce said on Friday that companies in the pharmaceutical sector ...
A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes ...
Digital media publisher Ziff Davis sued OpenAI in Delaware federal court on Thursday, accusing the Microsoft-backed ...
Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...
Erie Indemnity said on Thursday its first-quarter profit rose 11%, as the property and casualty insurer raked in higher fees from policies and earned more returns on its investments.
Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...
Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results